Adams L. A., Lymp J. F., St. Sauver J., Sanderson S. O., Lindor K. D., Feldstein A., Angulo P. (2005) The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129: 113-121.

BIBLIOGRAFIA

A

Abdelmegeed M. A., Banerjee A., Yoo S. H., Jang S., Gonzalez F. J., Song B. J.

(2012) Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat- induced non-alcoholic steatohepatitis. J Hepatol 57: 860-866.

Adams L. A., Lymp J. F., St. Sauver J., Sanderson S. O., Lindor K. D., Feldstein A., Angulo P. (2005) The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129: 113-121.

Adams L. A., Sanderson S., Lindor K. D., Angulo P. (2005) The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 41: 132-138.

Aebi H. (1984) Catalase in vitro. Methods enzymol 105: 121-126.

Aithal G. P., Thomas J. A., Kaye P. V., Lawson A., Ryder S. D., Spendlove I., Austin A. S., Freeman J. G., Morgan L., Webber J. (2008) Randomized, placebo- controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. Gastroenterology 135: 1176-1184.

Aitio A. (1978) A simple and sensitive assay of 7-ethoxycoumarin deethylation. Anal Biochem 85(2): 488-491.

Albano E., Mottaran E., Vidali M., Reale E., Saksena S., Occhino G., Burt A. D., Day C. P. (2005) Immune response towards lipid peroxidation products as a predictor of progression of nonalcoholic fatty liver disease to advanced fibrosis. Gut 54: 987-993.

Altenhoefer A., Oswald S., Sonnenborn U., Enders C., Schulze J., Hacker J., Oelschlaeger T. A. (2004) The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. FEMS Immunol Med Microbiol 40: 223-229.

Amato G., Longo V., Mazzaccaro A., Gervasi P. G. (1996) Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenase in rat liver.

Chem Res Toxicol 9 (1996): 882-890.

Angulo P., Keach J. C., Batts K. P., Lindor K. D. (1999) Indipendent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30: 1356-1362.

Anstee Q. M., Daly A. K., Day C. P. (2011) Genetic modifiers of non-alcoholic fatty liver disease progression. Biochim Biophys Acta 1812(11): 1557-1566.

Argo C. K., Northup P. G., Al-Osaimi A. M., Caldwell S. H. (2009) Systematic review of risk factors for fibrosis progression in nonalcoholic steatohepatitis. J Hepatol 51: 371-379.

Arkan M. C., Hevener A. L., Greten F. R., Maeda S., Li Z. W., Long J. M., Wynshaw-Boris A., Poli G., Olefsky J., Karin M. (2005) IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11: 191-198.

Arner P. (1998) Not all fat is alike. Lancet 351: 1301-1302.

Aubert J., Begriche K., Knockaert L., Robin M. A., Fromenty B. (2011). Increased expression of cytochromw P450 2E1 in Non-alcoholic fatty liver disease: mechanisms and pathophysiological role. Clin Res Hepatol Gastroenterol 35: 630-637.

B

Backes W. L., Sequeira D. J., Cawley G. F., Eyer C. S. (1993) Relationship between hydrocarbon structure and induction of P450: effects on protein levels and enzyme activities. Xenobiotica 23(12): 1353-1366.

Badary O. A., Abdel-Maksoud S., Ahmed W. A., Owieda G. H. (2005) Naringenin attenuates cisplatin nephrotoxicity in rats. Life Sci 18;76(18): 2125-2135.

Baldwin A. S. jr. (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14: 649-683.

Barnett C. R., Gibson G. G., Wolf C. R., Flatt P. R., Ioannides C. (1990) Induction of cytochrome P450III and P450IV family proteins in streptozotocin-induced diabetes.

Biochem J 268: 765-769.

Bataller R., Schwabe R. F., Choi Y. H., Yang L., Paik Y. H., Lindquist J., Qian T., Schoonhoven R., Hagedorn C. H., Lemasters J. J., Brenner D. A. (2003) NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 112: 1383-1394.

Baumgardner J. N., Shankar K., Hennings L., Albano E., Badger T. M., Ronis M.

J. (2008) N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis. J Nutr 138: 1872-1879.

Bellentani S., Tiribelli C., Saccoccio G., Sodde M., Fratti N., De Martin C., Cristianini G. (1994) Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology 20: 1442-1449.

Bellezza I., Mierla A. L., Minelli A. (2010) Nrf2 and NF- B and their concerted

modulation in cancer pathogenesis and progression. Cancers 2: 483-497.

Benson A. M., Hunkeler M. J., Talalay P. (1980) Increase of NAD(P)H: quinine reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci 77: 5216-5220.

Bergey D. H., Holt J. G., Krieg N. R. (1989) in: Bergey's manual of systematic bacteriology (vol. 3).

Berson A., Beco V. D., Letteron P., Robin M., Moreau C., Kahwaji J. E., Verthier N., Feldmann G., Fromenty B., Pessayre D. (1998) Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes.

Gastroenterology 114: 764-774.

Bindoli A., Cavallini L. (1980) in: I radicali liberi. Aspetti biochimici e medici. Piccin Editore.

Borruel N., Carol M., Casellas F., Antolín M., de Lara F., Espín E., Naval J., Guarner F., Malagelada J. R. (2002) Increased mucosal tumour necrosis factor alpha Gut 51: 659-664.

Brunner LJ., Bai S. (2000) Effect of dietary oil intake on hepatic cytochrome P450 in the rat. J Pharm Sci 89: 1022-1027.

Brunt E. M. (2001) Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21: 3-16.

Bugianesi E., Gentilcore E., Manini R., Natale S., Vanni E., Villanova N., David E., Rizzetto M., Marchesini G. (2005) A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol 100: 1082-1090.

Bugianesi E., Vanni E. (2002) La steatoepatite non alcolica (NASH): storia naturale.

Hepatology 1: 11-21.

Burt A. D., Mutton A., Day C. (1998) Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol 15: 246-258.

Byrne C. D., Olufad R., Bruce K. D., Cagampang F. R., Ahmed M. H. (2009) Metabolic disturbances in non-alcoholic fatty liver disease. Clin Sci (2009) 116: 539- 564.

C

Caballero-Franco C., Keller K., De Simone C., Chadee K. (2007) The VSL#3

probiotic formula induces mucin gene expression and secretion in colonic epithelial

cells. Am J Physiol Gastrointest Liver Physiol 292: 315-322.

Campfield L. A., Smith F. J., Burn P. (1996) The OB protein (leptin) pathway: a link between adipose tiusse mass and central neural networks. Horm Metab Res 28: 619- 632.

Camussi A., Moller F., Ottaviano E., Sari Gorla M. 1990 in: Metodi statistici per la sperimentazione biologica. Seconda edizione, Zanichelli.

Canbay A., Taimr P., Torok N., Higuchi H., Friedman S., Gores G. J. (2003) Apoptotic body engulfment by a human stellate cell line is profibrogenic. Lab Invest 83:

655-663.

Caro A. A., Cederbaum A. I. (2004). Oxidative stress, toxicology and pharmacology of CYP2E1. Annu Rev Pharmacol Toxicol 44: 27-42.

Carr F. J., Chill D., Maida N. (2002) The lactic acid bacteria: a literature survey. Crit Rev Microbiol 28(4): 281-370.

Cay D., Yuan M., Frantz D. F., Melendez P. A., Hansen L., Lee J., Shoelson S. E.

(2005) Local and systemic insulin resistance resulting from hepatic activation of IKK- beta and NF-kappaB. Nat Med 11: 183-190.

Cebra J. J., Priwal S. B., Lee G., Lee F., Shroff K. E. (1998) Development and maintenance of the gut-associated lymphoid tissue (GALT): the roles of enteric bacteria and viruses. Dev Immunol 6: 13-18.

Ceponis P. J., Botelho F., Richards C. D., McKay D. M. (2000) Interleukins 4 and 13 increase intestinal epithelial permeability by a phosphatidylinositol 3-kinase pathway.

Lack of evidence for STAT 6 involvement. J Biol Chem 275(37): 29132-29137.

Cesaro C., Tiso A., Del Prete A., Cariello R., Tuccillo C., Cotticelli G., del Vecchio Blanco C., Loguercio C. (2011) Gut microbiota and probiotics in chronic liver diseases. Dig Liver Dis. 43: 431-438.

Chalasani N., Gorski J., Asghar M., Asghar A., Foresman B., Hall S., Crabb D.

(2003) Hepatic cytochrome P4502E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology 37: 544-550.

Chatzigeorgiou A., Halapas A., Kalafatakis K., Kamper E. (2009) The use of animal models in the study of diabetes mellitus. In vivo 23(2): 245-58.

Chitturi S., Abeygunasekera S., Farrell G., Holmes-Walker J., Hui J., Fung C., Karim R., Lin R., Samarasinghe D., Liddle C., Weltman M., George J. (2002) NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35: 373-379.

Chitturi S., Farrell G. (2001) Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 21: 27-41.

Chitturi S., George J. (2003) Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis. Curr Gastroenterol Rep 5: 18-25.

Chowdhry S., Nazmy M. H., Meakin P. J., Dinkova-Kostova A. T., Walsh S. V., Tsujita T., Dillon J. F., Ashford M. L., Hayes J. D. (2010) Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis. Free Radic Biol Med 48(2): 357-371.

Clark J., Brancati F. L., Diehl A. M. (2002) Nonalcoholic fatty liver disease.

Gastroenterology 122: 1649-1657.

Collins J. K., Thornton G., Sulliva G. O. (1998) Selection of probiotic strains for human application. Int Dairy J 8: 487-490.

Cope K., Risby T. H., Diehl A. M. (2000) Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis.

Gastroenterology 119: 1399-1401.

Cortez-Pinto H., Carneiro de Moura1 M., Day C. P. (2006) Non-alcoholic steatohepatitis: from cell biology to clinical practice. J of Hepatol 44: 197-208.

Coskun O., Kanter M., Korkmaz A., Oter S. (2005) Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin- -cell damage in rat pancreas. Pharmacol Res 51: 117-123.

Crespo J., Cayon A., Fernandez-Gil P., Hernandez-Guerra M., Mayorga M., Dominguez-Diez A., Fernandez-Escalante J., Pons-Romero F. (2001) Gene expression of tumor necrosis factor alpha and TNF receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 34: 1158-1163.

Cummings J. H., Macfarlane G. T. (1997) Role of intestinal bacteria in nutrient metabolism. Clin Nutr 16: 3-11.

Cussons A. J., Watts G. F., Mori T. A., Stuckey B. G. (2009) Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovarian syndrome: a randomised controlled trial employing proton magnetic resonance spectroscopy. J Clin Endocrinol Metab 94: 3842-3848.

D

Dam-Larsen S., Franzmann M., Andersen I. B., Christoffersen P., Jensen L. B., Sorensen T. I., Becker U., Bendtsen F. (2004) Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut 53: 750-755.

Day C P. (2002) Nonalcoholic steatohepatitis (NASH): where are we now and where are we going? Gut 50: 585-588.

Day C. P., James O. F. W. (1998) Steatohepatitis: a tale of two hits. Gastroenterology 114: 842-845.

De Jonghe V., Coorevits A., Van Hoorde K., Messens W., Van Landschoot A., De Vos P., Heyndrickx M. (2011) Influence of storage conditions on the growth of Pseudomonas species in refrigerated raw milk. Appl Environ Microbiol 77(2): 460-470.

Delzenne N. M., Neyrinck A. M., Backhed F., Cani P. D. (2011) Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 7: 639- 646.

Ding W. X., Yin X. M. (2004) Dissection of the multiple mechanisms of TNF-alpha- induced apoptosis in liver injury. J Cell Mol Med 8: 445-454.

Dethlefsen L., Eckburg P. B., Bik E. M., Relman D. A. (2006) Assembly of the human intestinal microbiota. Trends Ecol Evol Sep;21(9): 517-523.

Do G. M., Oh H. Y., Kwon E. Y., Cho Y. Y., Shin S. K., Park H. J., Jeon S. M., Kim E., Hur C. G., Park T. S., Sung M. K., McGregor R. A., Choi M. S. (2011) Long-term adaptation of global transcription and metabolism in the liver of high-fat diet-fed C57BL/6J mice. Mol Nutri Food Res 55(Suppl.2): S173-S185.

Donahue B. S., Skottner-Lundin A., Morgan E. T. (1991) Growth hormone- dependent and independent regulation of cytochrome P-450 isozyme expression in streptozotocin-diabetic rats. Endocrinology 128: 2065-2076.

Dong Z., Hong J., Ma Q., Li D., Bullock J., Gonzales F. J., Park S. S., Gelboin H.

V., Yang C. S. (1988) Mechanism of induction of cytochrome P-450ac (P-450j) in chemically induced and spontaneously diabetic rats. Arch Biochem Biophys 263: 29- 35.

Dotan I., Rachmilewitz D. (2005) Probiotics in inflammatory bowel disease: possible mechanisms of action. Curr Opin Gastroenterol 21: 426-430.

Dowman J. K., Tomlinson J. W., Newsome P. N. (2010) Pathogenesis of non- alcoholic fatty liver disease. Q J Med 103: 71-83.

Dubos F., Pellisier J. P., Andrieux C., Ducluzeau R., Raibaud P. (1985) Inibitory effect of a copper-dipeptide complex on establishment of a Clostridium perenne strain in the intestinal tract of gnotobiotic mice. Appl Environ Microbiol 50: 1258-1261.

Ducluzeau R., Bellier M., Raibaud P. (1970) Transit through the digestive tract of the inocula of several bacterial strains introduced "per os" into axenic and "holoxenic"

mice. The antagonistic effect of the microflora of the gastrointestinal tract. Zbl Bakt I Orig 213: 533-548.

Duman D. G., Ozdemir F., Birben E., Keskin O., Eksioglu-Demiralp E., Celikel C.,

Kalayci O., Kalayci C. (2007) Effects of pentoxifylline on TNF-alpha production by

peripheral blood mononuclear cells in patients with nonalcoholic steatohepatitis. Dig Dis Sci 52: 2520-2524.

E

Elli M., Zink R., Rytz A., Reniero R., Morelli L. (2000) Iron requirement of Lactobacillus spp. In completely chemically defined growth media. J Appl Microbiol 88: 695-703.

Ellmann G. L. (1959) Tissue Sulphydryl Groups. Arch Biochem Biophys 82: 70-77.

Enomoto E., Ikejima K., Bradford B. U., Rivera C. A., Kono H., Goto M., Yamashina S., Schemmer P., Kitamura T., Oide H., Takei Y., Hirose M., Shimizu H., Miyazaki A., Brenner D. A., Sato N., Thurman R. G. (2000) Hepatology:

microcirculation and pathogenesis of alcoholic liver injury. Role of Kupffer cells and gut-derived endotoxins in alcoholic liver injury. J Gastroenterol Hepatol 15: D20-D25.

Eschenbach D. A., Davick P. R., Williams B. L., Klebanoff S. J., Young-Smith K., Critchlow C. M., Holmes K. K. (1989) Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 27(2): 251-256.

Esposito E., Iacono A., Bianco G., Autore G., Cuzzocrea S., Vajro P., Canani R. B., Calignano A., Raso G. M., Meli R. (2009) Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. J Nutr 139(5): 905-911.

F

Fabian E., Elmadfa I. (2006) Influence of daily consumption of probiotic and conventional yoghurt on the plasma lipid profile in young healthy women. Ann Nutr Metab 50(4): 387-393.

Fadok V. A., Bratton D. L., Konowal A., Freed P. W., Westcott J. Y., Henson P. M.

(1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2 and PAF. J Clin Invest 101: 890-898.

FAO/WHO expert consultation. (2001) Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria.

Fargion S., Mattioli M., Fracanzani A., Sampietro M., Tavazzi D., Fociani P.,

Taioli E., Valenti L., Fiorelli G. (2001) Hyperferritinemia, iron overload and multiple

metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J

Gastroenterol 96: 2448-2455.

Favreau L. V., Schenkman J. B. (1988) Cytochrome P-450 alteration in the BB/W or spontaneously diabetic rat. Biochem Pharmacol 37: 577-584.

Fedorak R. N., Madsen K. L. (2004) Probiotics and prebiotics in gastrointestinal disorders. Curr Opin Gastroenterol 20(2): 146-155.

Feldstein A. E., Canbay A., Angulo P., Taniai M., Burgart L. J., Lindor K. D., Gores G. J. (2003) Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125: 437-443.

Feldstein A. E., Werneburg N. W., Canbay A., Guicciardi M. E., Bronk S. F., Rydzewski R., Burgart L. J., Gores G. J. (2004) Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway Hepatology 40: 185-194.

Fernandez-Miranda C., Perez-Carreras M., Colina F., Lopez-Alonso G., Vargas C., Solis-Herruzo J. A. (2008) A pilot trial of fenofibrate for the treatment of nonalcoholic fatty liver disease. Dig Liver Dis 40: 200-205.

Folch J., Lees M., Sloane Stanley G. H. (1957) A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 226(1): 497-509.

Fuller R. (1989) Probiotics in man and animals. J Appl Bacteriol 66: 365-378.

Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Makishima M., Matsuda M., Shimomura I. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114:

1752-1761.

G

Galli A., Pinaire J., Fischer M., Dorris R., Crabb D. (2001) The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor alpha is inhibited by ethanol metabolism: a novel mechanism for the development of ethanol-induced fatty liver. J Biol Chem 276(1): 68-75.

Garcia-Monzon C., Martin-Perez E., Iacono O., Fernandez-Bermejo M., Majano P., Apolinario A., Larranaga E., Moreno-Otero R. (2000) Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol 33: 716-724.

Gareau M. G., Sherman P. M., Walker A. (2010) Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol 7: 503-514.

Gershman M. D., Kennedy D. J., Noble-Wang J., Kim C., Gullion J., Kacica M.,

Jensen B., Pascoe N., Saiman L., McHale J., Wilkins M., Schoonmaker-Boopo D.,

Clayton J., Arduino M., Srinivasan A. (2008) Multistate outbreak of Pseudomonas fluorescens bloodstream infection after exposure to contaminated heparinized saline flush prepared by a compounding pharmacy. Clin Infect Dis 47: 1372-1379.

Ghosh S., May M. J., Kopp E. B. (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225-260.

Giaccone V. (2010) in: Pseudomonas e prodotti lattiero-caseari. Medicina Veterinaria Preventiva 32.

Gill H. S., Rutherfurd K. J. (2001) Viability and dose-response studies on the effects of the immuno-enhancing lactic acid bacterium Lactobacillus rhamnosus in mice. Br J Nutr 86: 285-289.

Gilliland S. E, Morelli L., Reid G. (2001) Health and nutritrional properties of probiotics in food including powder milk with live lactic acid bacteria. In joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powdered milk (Cordoba, Argentina).

Goldin B. R. (1990) Intestinal microflora: metabolism of drugs and carcinogens. Ann Med 22: 43-48.

Goldin B. R., Gorbach S. L. (1980) Effect of Lactobacillus acidophilus dietary supplements on 1,2 dimethylhydrazine dihydrochloride-induced intestinal cancer in rats. J Natl Cancer Inst 64: 263-265.

Goodman Z. D. (2007) Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol 47(4): 598-607.

Grangette C., Nutten S., Palumbo E., Morath S., Hermann C., Dewulf J., Pot B., Hartung T., Hols P., Mercenier A. (2005) Enhanced anti-inflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci USA 102: 10321-10326.

Grozdanov L., Raasch C., Schulze J., Sonnenborn U., Gottschalk G., Hacker J., Dobrindt U. (2004) Analysis of the genome structure of the non-pathogenic probiotic Escherichia coli strain Nissle 1917. J Bacteriol 186: 5432-5441.

Guarner F., Khan A. G., Garisch J., Eliakim R., Gangl A., Thomson A., Krabshuis J., Lemair T., Kaufmann P., de Paula J.A., Fedorak R., Shanahan F., Sanders M.

E., Szajewska H., Ramakrishna B. S., Karakan T., Kim N., World Gastroenterology Organization (2012) World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol 46(6): 468-81.

Guarner F., Malagelada J. R. (2003) Gut flora in health and disease. Lancet 361:

512-519.

Guarner F., Schaafsma G. J. (1998) Probiotics. Int J Food Microbiol 39(3): 237-238.

Gueimonde M., Margolles A., De los Reyes-Gavilán C. G., Salminen S. (2007) Competitive exclusion of enteropathogens from human intestinal mucus by Bifidobacterium strains with acquired resistance to bile: a preliminary study. Int J Food Microbiol 113: 228-232.

H

Hajela N., Nair G. B., Abraham P., Ganguly N. K. (2012) Health impact of probiotics-vision and opportunities. Gut Pathog 4: 1.

Handshin C., Meyer U. A. (2003) Induction of drug metabolism: the role of nuclear receptors. Pharmacol Rev 55: 649-673.

Hasegawa T., Yoneda M., Nakamura K., Makino I., Terano A. (2001) Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non alcoholic steatohepatitis: a pilot study. Aliment Pharmacol Ther 15: 1667-1672.

Hindson J. C., Winter A. C. (2002) in: Manual of sheep diseases. Blackwell Publishing.

Hirayama K., Rafter J. (2000) The role of probiotic bacteria in cancer prevention.

Microbes Infect 2: 681-686.

Hlivak P., Odraska J., Ferencik M., Ebringer L., Jahnova E., Mikes Z. (2005) One- year application of probiotic strain Enterococcus faecium M-74 decreases serum cholesterol levels. Bratisl Lek Listy 106(2): 67-72.

Holtzclaw W. D., Dinkova-Kostova A. T., Talalay P. (2004) Protection against electrophile and oxidative stress by induction of phase 2 genes: the quest for the elusive sensor that responds to inducers. Adv Enzyme Regul 44: 335-367.

Hruszkewycz A. M. (1988) Evidence for mitochondrial DNA damage by lipid peroxidation. Biochem Biophys Res Commun 153: 191-197.

Hsueh P. R., Teng L. J., Pan H. J., Chen Y. C., Sun C. C., Ho S. W., Luh K. T.

(1998) Outbreak of pseudomonas fluorescens bacteremia among oncology patients. J Clin Microbiol 36(10): 2914-2917.

http://drnelson.utmem.edu/CytochromeP450.html

Hui J. M., Hodge A., Farrell G. C., Kench J. G., Kriketos A., George J. (2004)

Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 40: 46-54.

I

Iacono A., Raso G. M., Berni Canani R., Calignano A., Melia R. (2011) Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms. J Nutr Biochem 22: 699-711.

Imaoka S., Funae Y. (1991) Induction of cytochrome P450 isozymes in rat liver by methyl n-alkyl ketones and n-alkylbenzens. Biochem Pharmacol 42: S143-S150.

Ioannides-Demos L. L., Piccenna L., McNeil J. J. (2011) Pharmacotherapies for obesity: past, current, and future therapies. J Obes 2011: 179674.

Ishak K., Baptista A., Bianchi L., Callea F., De Groote J., Gudat F., Denk H., Desmet V., Korb G., MacSween R. N., et al. (1995) Histological grading and staging of chronic hepatitis. J Hepatol.22(6): 696-699.

Ishii T., Itoh K., Takahashi S., Sato H., Yanagawa T., Katoh Y., Bannai S., Yamamoto M. (2000) Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 275: 16023-16029.

Itoh K.,Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J. D., Yamamoto M. (1999) Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13: 76-86.

J

Jaiswal A. K., Burnett P., Adesnik M., McBride O. W. (1990) Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6. Biochemistry 29(7): 1899-1906.

Jensen M. D., Haymond M., Rizza R., Cryer P., Miles J. (1989) Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 83: 1168-1173.

Jeong W. I., Jeong D. H., Do S. H., Kim Y. K., Park H. Y., Kwon O. D., Kim T. H., Jeong K. S. (2005) Mild hepatic fibrosis in cholesterol and sodium cholate diet-fed rats. J Vet Med Sci 67: 235-242.

Johansson I., Lindros K.O., Eriksson H., Ingelman-Sundberg M. (1990) Transcriptional control of CYP2E1 in the perivenous liver region and during starvation. Biochem Biophys Res Commun 173: 331-338.

Jones B. V, Marchesi J. R. (2007) Accessing the mobile metagenome of the human gut microbiota. Mol Biosyst 3: 749-758.

Jun C. D., Kim Y., Choi E. Y., Kim M., Park B., Youn B., Yu K., Choi K. S., Yoon K. H., Choi S. C., Lee M. S., Park K. I., Choi M., Chung Y., Oh J. (2006) Gliotoxin reduces the severity of trinitrobenzene sulfonic acid-induced colitis in mice: evidence of the connection between heme oxygenase-1 and the nuclear factor-kappaB pathway in vitro and in vivo. Inflamm Bowel Dis 12: 619-629.

Juurlink D. N., Gomes T., Lipscombe L. L., Austin P. C., Hux J. E. Mamdani M.

M. (2009) Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study. BMJ 18(339): 2942.

K

Kakkar R., Mantha S.V., Radhi J., Prasad K., Kalra J. (1998); Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes;

Clin Sci 94: 623-632.

Kalyanaraman B. (2013) Teaching the basics of redox biology to medical and graduate students: Oxidants, antioxidants and disease mechanisms. Redox Biol 1: 244- 257.

Kanagasabapathy G., Malek S. N., Mahmood A. A., Chua K. H., Vikineswary S., Kuppusamy U. R. (2013) Beta-Glucan-Rich Extract from Pleurotus sajor-caju (Fr.) Singer Prevents Obesity and Oxidative Stress in C57BL/6J Mice Fed on a High-Fat Diet. Evid Based Complement Alternat Med, eCAM, Article ID 185259.

Kanninen K., Heikkinen R., Malm T., Rolova T., Kuhmonen S., Leinonen H., Yla- Herttuala S., Tanila H., Levonen A. L., Koistinaho M., Koistinaho J. (2009).

Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial Proc Natl Acad Sci USA 106:

16505-16510.

Kanter M., Coskun O., Korkmaz A., Oter S. (2004) Effects of Nigella sativa on -cell damage in streptozotocin-induced diabetic rats. Anat Rec A Discov Mol Cell Evol Biol 279: 685-691.

Kaplan L. M. (1998) Leptin, obesity and liver disease. Gastroenterology 115: 997- 1001.

Kaser S., Moschen A., Cayon A., Kaser A., Crespo J., Pons-Romero F., Ebenbichler C. F., Patsch J. R., Tilg H. (2005) Adiponectin and its receptors in nonalcoholic steatohepatitis. Gut 54: 117-121.

Kathirvel E., Morgan K., French S. W., Morgan T. R. (2009) Overexpression of

liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic

mouse model of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 21: 973-

983.

Kato R., Yamazoe Y. (1992) Sex-specific cytochrome P450 as a cause of sex and species- related differences in drug toxicity. Toxicol Lett 64/65:661-667.

Kawasaki T., Igarashi K., Koeda T., Sugimoto K., Nakagawa K., Hayashi S., Yamaji R., Inui H., Fukusato T., Yamanouchi T. (2009) Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis. J Nutr 139: 2067-2071.

Kirkland R. A., Windelborn J. A., Kasprzak J. M., Franklin J. L. (2002) A Bax- induced pro-oxidant state is critical for cytochrome c release during programmed neuronal death. J Neurosci 22: 6480-6490.

Ko I. Y., Park S. S., Song B. J., Patten C., Tan Y. Z., Hah Y. C., Yang C. S., Gelboin H. V. (1987) Monoclonal antibodies to ethanol-induced rat liver cytochrome P-450 that metabolizes aniline and nitrosamines. Cancer Res 47: 3101-3109.

Kobayashi E., Suzuki T., Yamamoto M. (2013) Roles Nrf2 plays in myeloid cells and related disorders. Oxid Med Cell Longev. Article ID 529219.

Kobayashi M., Yamamoto M. (2006) Nrf2-Keap 1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Advan Enzyme Regul 46: 113-140.

Kostic A. D., Howitt M. R., Garrett W. S. (2013) Exploring host-microbiota interactions in animal models and humans. Genes Dev 27: 701-718.

Kral J., Schaffner F., Pierson R., Wang J. (1993) Body fat topography as an indipendent predictor of fatty liver. Metabolism 42: 548-551.

(2011) The effect of rat strain, diet composition and feeding period on the development of a nutritional model of nonalcoholic fatty liver disease in rats. Physiol Res 60: 317-328

Kumar M., Verma V., Nagpal R., Kumar A., Behare P. V., Singh B., Aggarwal P.

K. (2011) Anticarcinogenic effect of probiotic fermented milk and Chlorophyllin on aflatoxin-B1 induced liver carcinogenesis in rats. Br J Nutr 107: 1006-1016.

Kwon do Y., Jung Y. S., Kim S. J., Park H. K., Park J. H., Kim Y. C. (2009) Impaired sulfur-aminoacid metabolism and oxidative stress in nonalcoholic fatty liver are alleviated by betaine supplementation in rats. J Nutr 139: 63-68.

L

Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of the head

of bacteriophage T4. Nature 227:680.

Lam B., Younossi Z. M. (2010) Treatment options for nonalcoholic fatty liver disease.

Ther Adv Gastroenterol 3(2): 121-137.

Lanning D. K., Rhee K. J., Knight K. L. (2005) Intestinal bacteria and development of the B-lymphocyte repertoire. Trends Immunol 26: 419-425.

Larter C. Z., Chitturi S., Heydet D., Farrell G. C. (2010) A fresh look at NASH pathogenesis. Part 1: the metabolic movers. J Gastroenterol Hepatol 25(4): 672-690.

Leclercq I. A., Farrell G. C., Schriemer R., Robertson G. R. (2002) Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol 37: 206- 213.

Lee H. Y., Park J. H., Seok S. H., Baek M. W., Kim D. J., Lee K. E., Paek K. S., Lee Y., Park J. H. (2006) Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice. Biochim Biophys Acta 1761(7): 736-744.

Leung T. M., Nieto N. (2012) CYP2E1 and oxidant stress in alcoholic and non- alcoholic fatty liver disease. J Hepatol., 58(2): 395-398.

Levonen A. L., Inkala M., Heikura T., Jauhiainen S., Jyrkkanen H. K., Kansanen E., Maatta K., Romppanen E., Turunen P., Rutanen J., Yla-Herttuala S. (2007) Nrf2 gene transfer inducesantioxidant enzymes and suppresses smooth muscle cell growth in vitro and reduces oxidative stress in rabbit aorta in vivo. Arterioscler Thromb Vasc Biol 27: 741-747.

Lewis J. H., Mortensen M. E., Zweig S. (2007) Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Hepatology 46: 1453-1463.

Ley R. E., Backhed F., Turnbaugh P., Lozupone C. A, Knight R. D., Gordon J. I.

(2005) Obesity alters gut microbial ecology. P Natl Acad Sci USA 102: 11070-11075.

Ley R. E., Hamady M., Lozupone C., Turnbaugh P. J., Ramey R. R., Bircher J. S., Schlegel M. L., Tucker T. A., Schrenzel M. D., Knight R., Gordon J. I. (2008) Evolution of mammals and their gut microbes. Science 320: 1647-1651.

Ley R. E., Turnbaugh P. J., Klein S., Gordon J. I. (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022-1023.

Li Z., Yang S., Lin H., Huang J., Watkins P. A., Moser A. B., Desimone C., Song X.

Y., Diehl A. M. (2003) Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37(2): 343-350.

Lidbeck A., Geltner A. U., Orrhage K. M., Ottova L., Brismar B., Gustafsson J. A.,

Rafter J. J., Nord C. E. (1991) Impact of Lactobacillus acidophilus supplements on the

fecal microflora and soluble fecal bile acids in colon cancer patients. Microb Ecol Health Dis 4: 81-88.

Lieber C. S., Leo M. A., Mak K. M., Xu Y., Cao Q., Ren C., Ponomarenko A., Decarli L. M. (2004) Model of nonalcoholic steatohepatitis. Am J Clin Nutr 79: 502- 509.

Lin H. Z., Yang S., Chuckaree C., Kuhajda F., Ronnet G., Diehl A. (2000) Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med 6: 998- 1003.

Lirussi F., Mastropasqua E., Orando S., Orlando R. (2007) Probiotics for non- alcoholic fatty liver disease and/or steatohepatitis. Cochrane Database Syst Rev (1):CD005165.

Lluis J. M., Colell A., Garcia-Ruiz C., Kaplowitz N., Fernandez-Checa J. C. (2003) Acetaldehyde impairs mitochondrial glutathione transport in HepG2 cells through endoplasmic reticulum stress. Gastroenterology 124: 708-724.

Lockman K. A., Nyirenda M. J. (2010) Interrelationships between hepatic fat and insulin resistance in non-alcoholic fatty liver disease. Curr Diabetes Rev 6(5): 341-347.

Loguercio C., De Simone T., Federico A., Terracciano F., Tuccillo C., Di Chicco M., Cartenì M. (2002) Gut-liver axis: a new point of attack to treat chronic liver damage? Am J Gastroenterol 97(8): 2144-2146.

Loguercio C., Federico A., Tuccillo C., Terracciano F., D'Auria M. V., De Simone C., Del Vecchio Blanco C. (2005) Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J Clin Gastroenterol 39: 540- 543.

Loomba R., Lutchman G., Kleiner D., Ricks M., Feld J. J., Borg B. B., Modi A., Nagabhyru P., Sumner A. E., Liang T. J., Hoofnagle J. H. (2008) Clinical trial: pilot study of metformin for the treatment of nonalcoholic steatohepatitis. Ailment Pharmacol Ther 29(2): 172-182.

Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. (1951). Protein measurement with the Folin phenol reagent J Biol. Chem 193: 265-275.

Lubet R. A., Mayer R. T., Cameron J. W., Nims R. W., Burke M. D., Wolff T., Guengerich F. P. (1985) Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Arch Biochem Biophys 238: 43 48.

Ludwig J., Hashimoto E., Porayko M., Moyer T., Baldus W. (1997) Hemosiderosis

in cirrhosis: a study of 447 native livers. Gastroenterology 112: 882-888.

Ludwing J., Viggiano T. R., McGill D. B., Oh B. J. (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55: 434-438.

Lutchman G., Modi A., Kleiner D. E., Promrat K., Heller T., Ghany M. Borg B., Loomba R., Liang T. J., Premkumar A., Hoofnagle J. H. (2007) The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis. Hepatology 46:

424-429.

M

Ma D., Forsythe P., Bienenstock J. (2004) Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor -induced interleukin-8 expression. Infect Immun 72: 5308-5314.

Ma X., Hua J., Li Z. (2008) Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J Hepatol 49(5): 821-830.

Macdonought F. E., Wells P., Wong N. P. (1983) Mechanism of lactose utilisation by lactic acid streptococci: enzymatic and genetic analysis. J Bacteriol 102: 804-809.

Mackie R. I., Sghir A., Gaskins H. R. (1999) Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 69(5): 1035S-1045S.

Macpherson A., Khoo U. Y., Forgacs I., Philpott-Howard J., Bjarnason I. (1996) Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 38: 365-375.

Maddux B. A., Sbraccia P., Kumakura S., Sasson S., Youngren J., Fisher A., Spencer S., Grupe A., Henzel W., Stewart T., Reaven G. M., Goldfine I. D. (1995) Membrane glycoprotein PC-1 and insulin resistance in non insulin-dependent diabetes mellitus. Nature 373: 448-451.

Maeda N., Shimomura I., Kishida K., Nishizawa H., Matsuda M., Nagaretani H., Furuyama N., Kondo H., Takahashi M., Arita Y., Komuro R., Ouchi N., Kihara S., Tochino Y., Okutomi K., Horie M., Takeda S., Aoyama T., Funahashi T., Matsuzawa Y. (2002) Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8: 731-737.

Marchesini G., Brizi M., Bianchi G., Tomassetti S., Bugianesi E., Lenzi M., McCullough A., Natale S., Forlani G., Melchionda N. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50: 1844-1850.

Mari M., Colell A., Morales A., Paneda C., Varela-Nieto I., Garcia-Ruiz C.,

Fernandez-Checa J. C. (2004) Acidic sphingomyelinase downregulates the liver

specific methionine adenosyltransferase 1A, contributing to tumor necrosis factor- induced lethal hepatitis. J Clin Invest 113: 895-904.

Marino-Buslje C., Martin-Martinez M., Mizuguchi K., Siddle K., Blundell T. L.

(1999) The insulin receptor: from protein sequence to structure. Biochem Soc Trans 27(4): 715-726.

Mark M., Teletin M., Antal C., Wendling O., Auwerx J., Heikkinen S., Khetchoumian K., Argmann C. A., Dgheem M. (2007) Histopathology in mouse metabolic investigations current protocols in molecular biology. Curr Protoc Mol Biol 29B.4.1-29B.4.32.

Marklund S, Marklund G. (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47(3): 469-474.

Matsuo K., Ota H., Akamatsu T., Sugiyama A., Katsuyama T. (1997) Histochemistry of the surface mucous gel layer of the human colon.Gut 40: 782-789.

Matsuzawa Y., Shimomura I., Nakamura T., Keno Y., Totani K., Tokunaga K.

(1995) Pathophysiology and pathogenesis of visceral fat obesity. Obes 3 (suppl 2):

187S-194S.

Matteoni C. A., Younossi Z., Gramlich T., Boparai N., Liu Y., McCullough A.

(1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116: 1413-1419.

Medina J., Fernandez-Salazar L. I., Garcia-Buey L., Moreno-Otero R. (2004) Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diabetes Care 27: 2057-2066.

Mezey E. (1998) Dietary fat and alcoholic liver disease. Hepatology 28: 901-905.

Mihara M., Uchiyama M. (1978) - Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86(1): 271-278.

Mnafgui K., Hamden K., Ben Salah H., Kchaou M., Nasri M., Slama S., Derbali F., Allouche N., Elfeki A. (2012) Inhibitory Activities of Zygophyllum album: A Natural Weight-Lowering Plant on Key Enzymes in High-Fat Diet-Fed Rats. Evid Based Complement Alternat Med 2012: 620384.

Musso G., Gambino R., Michieli F. D., Cassader M., Rizzetto M., Durazzo M., Faga E., Silli B., Pagano G. (2003) Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 37:

909-916.

N

Nagai H., Matsumaru K., Feng G., Kaplowitz N. (2002) Reduced glutathione depletion causes necrosis and sensitization to tumor necrosis factor-alpha-induced apoptosis in cultured mouse hepatocytes. Hepatology 36: 55-64.

Nagpal R., Kumar A., Kumar M., Behare P. V., Jain5 S., Yadav H. (2012) Probiotics, their health benefits and applications for developing healthier foods: a review. FEMS Microbiol Lett 1-15.

Naughton P., Foresti R., Bains S. K., Hoque M., Green C. J., Motterlini R. (2002) Induction of Heme Oxygenase-1 by nitrosative stress. A role for nitroxyl anion. J Biol Chem 277(43): 40666-40674.

Nebert D. W., Nelson D. R., Coon M. J., Estabrook R. W., Feyereisen R., Fujii- Kuriyama Y., Gonzalez F. J., Guengerich F. P., Gunsalus I. C., Johnson E. F.

(1991) The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. DNA Cell Biol 10(1): 1-14.

Nelson D. R., Koymans L., Kamataki T., Stegeman J. J., Feyereisen R., Waxman D. J., Waterman M. R., Gotoh O., Coon M. J., Estabrook R. W., Gunsalus I. C., Nebert D. W. (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6: 1-42.

Neuschwander-Tetri B. A., Caldwell S. H. (2003) Nonalcoholic steatohepatitis:

summary of an AASLD single topic conference. Hepatology 37: 1202-1209.

Nguyen T., Nioi P., Pickett C. B. (2009) The Nrf2-antioxidant response element signalling pathway and its activation by oxidative stress. J Biol Chem 20: 13291-13295.

Nieves D. J., Cnop M., Retzlaff B., Walden C. E., Brunzell J. D., Knopp R. H., Kahn S. E. (2003) The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes 52: 172-179.

Nishikawa S., Sugimoto J., Okada M., Sakairi T., Tagaki S. (2012) Gene expression in livers of BALB/C and C57BL/6J micr fed a high-fat diet. Toxicol Pathol 40: 71-82.

Nissle S. (1916) Ueber die Grundlagen einer neuen ursaechlichen Bekaempfung der pathologischen Darmflora. Deutsch Med Woch 42: 1181-1184.

O

Oben J. A., Roskams T., Yang S., Lin H., Sinelli N., Li Z., Torbenson M., Thomas S. A., Diehl A. M. (2003) Norepinephrine induces hepatic fibrogenesis in leptin deficient ob/ob mice. Biochem Biophys Res Commun 308: 284-292.

Oelschlaeger T. A. (2010) Mechanisms of probiotic actions-a review. Int J Food Microbiol 300: 57-62.

Oh M. K., Winn J., Poordad F. (2008) Review article: diagnosis and treatment of nonalcoholic fatty liver disease. Ailment Pharmacol Ther 28: 503-522.

Ohashi Y., Ushida K. (2009) Health-beneficial effects of probiotics: its mode of action.

Anim Sci J 80: 361-371.

Omura T., Sato R. (1964) The carbon-monoxide binding protein of liver microsomes.

Evidence for its hemoprotein nature. J Biol Chem 292: 2370-2378.

Ong J. P., Pitts A., Younossi Z. M. (2008) Increased overall mortality and liver- related mortality in nonalcoholic fatty liver disease. J Hepatol 49: 608-612.

Ong J. P., Younossi Z. M. (2007) Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis 11: 1-6.

Orellana M., Guajardo V. (2004) Cytochrome P450 activity and its alteration in different diseases. Rev Med Chil 132(1): 85-94.

Ortiz de Montellano P. (1995) The 1994 Bernard B. Brodie Award Lecture. Structure, mechanism, and inhibition of cytochrome P450. Drug Metab Dispos 23(11): 1181-1187.

Oz H. S., Im H. J., Chen T. S., de Villiers W. J., McClain C. J. (2006) Glutathione- enhancing agents protect against steatohepatitis in a dietary model. J Biochem Mol Toxicol 20: 39-47.

Ozcan U., Cao Q., Yilmaz E., Lee A. H., Iwakoshi N. N., Ozdelen E., Tuncman G., Gorgun C., Glimcher L. H., Hotamisligil G. S. (2004) Endoplasmic reticulum stress links obesity, insulin action and type 2 diabetes. Science 306: 457-461.

P

Pagano G., Pacini G., Musso G., Gambino R., Mecca F., Depetris N., Cassader M., David E., Cavallo-Perin P., Rizzetto M. (2002) Nonalcoholic steatohepatitis, insulin resistance and metabolic syndrome: further evidence for an etiologic association.

Hepatology 35: 367-372.

Paik H. D., Park J. S., Park E. (2005) Effects of Bacillus polyfermenticus SCD on lipid and antioxidant metabolism in rats fed a high-fat and high-cholesterol diet. Biol Pharm Bull 28(7): 1270-1274.

Pan M., Song Y. L., Xu J. M., Gan H. Z. (2006) Melatonin ameliorates nonalcoholic

fatty liver induced by high-fat diet in rats. J Pineal Res 41: 79-84.

Paradis V., Perlemuter G., Bonvoust F., Dargere D., Parfait B., Vidaud M., Conti M., Huet S., Ba N., Buffet C., Bedossa P. (2001) High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology 34: 738-744.

Parveen K., Khan M. R., Mujeeb M., Siddiqui W. A. (2010) Protective effects of Pycnogenol on hyperglycemia-induced oxidative damage in the liver of type 2 diabetic rats. Chem Biol Interact 186: 219-227.

Pascussi J. M., Gerbal-Chaloin S., Drocourt L., Assenat E., Larrey D., Pichard- Garcia L., Vilarem M. J., Maurel P. (2004) Cross-talk between xenobiotic detoxication and other signaling pathways: clinical and toxicological consequences.

Xenobiotica 34: 633-664.

Patel T. R., Jackman D. M., Bartlett F. M. (1983) Heat-stable protease from pseudomonas fluorescens T16: purification by affinity column chromatography and characterization. Appl Environ Microbiol 46(2): 333-337.

Pereira D. I. A., Gibson G. R. (2002) Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut. Appl Environ Microbiol 68: 4689- 4693.

Perez-Carreras M., Del Hoyo P., Martin M. A., Rubio J. C., Martin A., Castellano G., Colina F., Arenas J., Solis-Herruzo J. A. (2003) Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 38: 999- 1007.

Pessayre D., Bearson A., Fromenty B., Mansour A. (2001) Mitochondria in steatohepatitis. Semin Liver Dis 21: 57-69.

Pessayre D., Fromenty B. (2005) NASH: a mitochondrial disease. J Hepatol 42: 928- 940.

Pessayre D., Mansouri A., Fromenty B. (2002) Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis. Am J Physiol Gastrointest Liver Physiol 282: G193-G199.

Petrof E. O., Kojima K., Ropeleski M. J., Musch M. W., Tao Y., De Simone C., Chang E. B. (2004) Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 127(5): 1474-1487.

Porter T. D., Coon M. J. (1991) Cytochrome P-450. multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms. J Biol Chem 266: 13469-13472.

Preston G. M. (2004) Plant perceptions of plant growth-promoting Pseudomonas.

Philos Trans R Soc Lond B Biol Sci 359(1446): 907-918.

Purohit V., Abdelmalek M. F., Barve S., Benevenga N. J., Halsted C. H., Kaplowitz N., Kharbanda K. K., Liu Q. Y., Lu S. C., McClain C. J., Swanson C., Zakhari S.

(2007) Role of S-adenosylmethionine, folate and betaine in the treatment of alcoholic liver disease: summary of a symposium. Am J Clin Nutr 86: 14-24.

Q

Qin J., Li R., Raes J., Arumugam M., Burgdorf K. S., Manichanh C., Nielsen T., Pons N., Levenez F., Yamada T., Mende D. R., Li J., Xu J., Li S., Li D., Cao J., Wang B., Liang H., Zheng H., Xie Y., Tap J., Lepage P., Bertalan M., Batto J. M., Hansen T., Le Paslier D., Linneberg A., Nielsen H. B., Pelletier E., Renault P., Sicheritz-Ponten T., Turner K., Zhu H., Yu C., Li S., Jian M., Zhou Y., Li Y., Zhang X., Li S., Qin N., Yang H., Wang J., Brunak S., Dore J., Guarner F., Kristiansen K., Pedersen O., Parkhill J., Weissenbach J.; MetaHIT Consortium, Bork P., Ehrlich S. D., Wang J. (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285): 59-65.

R

Rabot S., Rafter J., Rijkers G. T., Watzl B., Antoine J. M. (2010) Guidance for substantiating the evidence for beneficial effects of probiotics: impact of probiotics on digestive system metabolism. J Nutr 140: 677S-689S.

Rafiq N., Bai C., Fang Y., Srishord M., McCullough A., Gramlich T., Younossi Z.

M. (2009) Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 7: 234-238.

Rangasamy T, Guo J., Mitzner W. A., Roman J., Singh A., Fryer A. D., Yamamoto M., Kensler T. W., Tuder R. M., Georas S. N., Biswal S. (2005) Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med 202: 47-59.

Rashid A., Wu T., Huang C., Chen C., Lin H., Yang S., Lee F., Diehl A. (1999) Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 29: 1131-1138.

Ratziu V., Giral P., Jacqueminet S., Charlotte F., Hartemann-Heurtier A., Serfaty L. Podevin P, Lacorte J. M., Bernhardt C., Bruckert E., Grimaldi A., Poynard T.;

LIDO Study Group. (2008) Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial. Gastroenterology 135: 100-110.

Rayan D. E., Lewin W. (1990) Purification and characterization of hepatic microsomal cytochrome P-450. Pharmacol Ther 45: 153-239.

Reinke L. A., Moyer M. J. (1985) p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol. Drug Metab Dispos 13: 548-552.

Reinke L. A., Rosemberg H., Stohs S. J. (1978) Altered metabolism of androstenedione by hepatic microsomes from streptozotocin-diabetic male rats. Res Commun Chem Pathol Pharmacol 19: 445-452.

Resta S. C. (2008) Effects of probiotics and commensals on intestinal epithelial physiology: implications for nutrient handling. J Physiol 587: 4169-4174.

Reynet C., Kahn C. (1993) Rad: a member of the Ras family overexpressed in muscle of type 2 diabetic humans. Science 262: 1441-1444.

Rizki G., Arnaboldi L., Gabrielli B., Yan J., Lee G. S., Ng R. K., Turner S. M., Badger T. M., Pitas R. E., Maher J. J. (2006) Mice fed a lipogenic methionine- choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1. J Lipid Res 47(10): 2280-2290.

Roberts E. A. (2005) Non-alcoholic fatty liver disease (NAFLD) in children. Front Biosci 10: 2306-2318.

Robertson G., Leclercq I., Farrell G. (2001) Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol 281: G1135-G1139.

Ron D. (2002) Translational control in the endoplasmic reticulum stress response. J Clin Invest 110: 1383-1388.

Ross D., Beall H., Traver R. D., Siegel D., Phillips R. M., Gibson N. W. (1994) Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies. Oncol Res 6(10-11): 493-500.

Ruhl C. E., Everhart J. E. (2003) Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 124: 71-79.

S

Samarghandian S., Borji A., Delkhosh M.B., Samini F. (2013) Safranal tratement improves hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats. J Pharm Sci 16(2): 352-362.

Sambrook J., Russell D. W. (2006) SDS-Polyacrylamide Gel Electrophoresis of

Proteins. CSH Protoc Sep 1; 2006(4).

Sanyal A. J. (2002) Technical review on nonalcoholic fatty liver disease.

Gastroenterology 123: 1705-1725.

Sanyal A. J., Campbell-Sargent C., Mirshahi F., Rizzo W. B., Contos M. J., Sterling R. K., Luketic V. A., Shiffman M. L., Clore J. N. (2001) Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.

Gastroenterology 120: 1183-1192.

Satapathy S. K., Sakhuja P., Malhotra V., Sharma B. C., Sarin S. K. (2007) Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with nonalcoholic steatohepatitis. J Gastroenterol Hepatol 22: 634-638.

Savage D. C. (1977) Microbial ecology of the gastrointestinal tract. Ann Rev Microbiol 31: 107-133.

Savage D. C. (1986) Gastrointestinal microflora in mammalian nutrition. Ann Rev Nutr 6: 155-178.

Savaiano D. A., AbouElAnouar A., Smith D. E., Levitt M. D. (1984) Lactose malabsorption from yogurt, pasteurized yogurt, sweet acidophilus milk and cultured milk in lactase-deficient individuals. Am J Clin Nutr 40: 1219-1223.

Sazci A., Akpinar G., Aygun C., Ergul E., Senturk O., Hulagu S. (2008) Association of apolipoprotein E polymorphisms in patients with non-alcoholic steatohepatitis. Dig Dis Sci 53(12): 3218-3224.

Scaglioni F., Ciccia S., Marino M., Bedogni G., Bellentani S. (2011) ASH and NASH.

Dig Dis 29(2): 202-210.

Schattenberg J. M., Wang Y., Singh R., Rigoli R. M., Czaja M. J. (2005) Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insuli signaling. J Biol Chem 280: 9887-9894.

Schlager J. J., Powis G. (1990) Cytosolic NAD(P)H:(quinone-acceptor)oxidoreductase in human normal and tumor tissue: effects of cigarette smoking and alcohol. Int J Cancer 45(3): 403-409.

Schmatz R., Belmonte Perreira L., Stefanello N., Mazzanti C., Spavenello R., Gutierres J., Bagatini M., Xurry Martins C., Husein Abdalla F., Serres J.D., Zanini D., Marchi Vieira J., Machado Cardoso A., Schetinger M.R., Morsch V.M.

(2011) Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta-aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats; Biochimie 94 (2012) 374-383.

Seldon M. P., Silva G., Pejanovic N., Larsen R., Gregoire I. P., Filipe J., Anrather

J., Soares M. P. (2007) Heme oxygenase-1 inhibits the expression of adhesion

molecules associated with endothelial cell activation via inhibition of NF-kappaB RelA

phosphorylation at serine 276. J Immunol 179: 7840-7851.

Shanahan F. (2002) . Lancet 359: 62-69.

Shanahan F. (2004) Probiotics in inflammatory bowel disease-therapeutic rationale and role. Adv Drug Deliv Rev 56(6): 809-818.

Sharma A. K., Bharti S., Ojha S., Bhatia J., Kumar N., Ray R., Kumari S., Arya D.

S. (2011) Up-regulation of PPAR , heat shock protein-27 and -72 by naringin attenuates insulin resistance, -cell dysfunction, hepatic steatosis and kidney damage in a rat model of type 2 diabetes. Br J Nutr 106(11): 1713-1723.

Shifflet A., Wu G. Y. (2009) Nonalcoholic steatohepatitis: an overview. J Formos Med Assoc 108: 4-12.

Shimojo N., (1994) Cytochrome P450 changes in rats with streptozotocin-induced diabetes. Int J Biochem 26; 1261-1268.

Shimojo N., Ishizaki T., Imaoka S., Funae Y., Fujii S., Okuda K. (1993) Changes in amounts of cytochrome P450 isozymes and level of catalytic activities in hepatic and renal microsomes of rats with streptozotocin-induced diabetes. Biochem Pharmacol 34:

287-289.

Siitonen S., Vapaatalo H., Salminen S. (1990) Effect of Lactobacillus GG yogurt in prevention of antibiotic associated diarrhoea. Ann Med 22: 57-59.

Smits H. H., Engering A., van der Kleij D., de Jong E. C., Schipper K., van Capel T. M., Zaat B. A., Yazdanbakhsh M., Wierenga E. A., van Kooyk Y., Kapsenberg M. L. (2005) Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin. Immunol 115: 1260-1267.

Solga S. F., Diehl A. M. (2003) Nonalcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics. J Hepatol 38: 681-687.

Song B. L., Matsunaga T., Hardwick J. P., Park S. S., Veech R. L., Yang C. S., Gelboin H. V., Gonzalez F. J. (1987) Stabilization of cytochrome P450j messenger ribonucleic acid in the diabetic rat. Mol Endocrinol 1: 542-547.

Srinivasan K., Viswanad B., Asrat L., Kaul C.L., Ramarao P. (2005) Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharm Res 52: 313-320.

Stresser D. M., Blanchard A. P., Turner S. D., Erve J. C., Dandeneau A. A., Miller

V. P., Crespi C. L. (2000) Substrate-dependent modulation of CYP3A4 catalytic

activity: analysis of 27 test compounds with four fluorimetric substrates. Drug Metab

Dispos 28: 1440-1448.

Sudha M. R., Bhonagiri S., Kumar M. A. (2013) Efficacy of Bacillus clausii strain UBBC-07 in the treatment of patients suffering from acute diarrhoea. Benef Microbes 1;4(2): 211-216.

Sutyak K. E., Wirawan R. E., Aroutcheva A. A., Chikindas M. L. (2008) Isolation of the Bacillus subtilis antimicrobial peptide subtilosin from the dairy product-derived Bacillus amyloliquefaciens. J Appl Microbiol 104(4): 1067-1074.

T

Tagg J. R., Dierksen K. P. (2003)

warfar Trends Biotechnol 21(5): 217 223.

Tajima M., Ikarashi N., Igeta S., Toda T., Ishii M., Tanaka Y., Machida Y., Ochiai W., Yamada H., Sugiyama K. (2013) Different diets cause alterations in the enteric environment and trigger changes in the expression of hepatic cytochrome P450 3A, a drug-metabolizing enzyme. Biol Pharm Bull 36(4): 624-634.

Tannenbaum G. S., Rorstad O., Brazeau P. (1979) Effects of prolonged foot deprivation on the ultradian growth hormone rhythm and immunoreactive somatostatin tissue levels in the rat. Endocrinology 104: 1733-1738.

Thimmulappa R. K., Lee H., Rangasamy T., Reddy S. P., Yamamoto M., Kensler T. W., Biswal S. (2006) Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest 116: 984-995.

Thummel K. E., Schenkman J. B. (1990) Effects of testosterone and growth hormone treatment on hepatic microsomal P450 expression in the diabetic rat. Mol Pharmacol 37: 119-129.

Towbin H., Staehelin T., Gordon J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Biotechnology 24: 145-149.

Turnbaugh P. J., Ley R. E., Mahowald M. A., Magrini V., Mardis E. R., Gordon J.

I. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.

U

Umesaki Y., Setoyama H. (2000) Structure of the intestinal flora responsible for development of the gut immune system in a rodent model. Microbes Infect 2: 1343- 1351.